Dermax Medical Named a Hangzhou 'New Force' Enterprise, Cementing Its Role as a Future Industry Leader

11Month7On [date], the Hangzhou Economic and Information Technology Bureau announced the first batch of [content] in Hangzhou."New Force" EnterprisesRecognition List: Valgen Medtech Co., Ltd. successfully selected. This title is awarded by Hangzhou City for...Cultivate leading enterprises and "chain leader" enterprisesThe core cultivation梯队, which was established, possessesLead Industry Transformation, Reshape Market StructureThe "New Forces" Core.

"The New Forces" Enterprise Selection aims to discover and cultivate core enterprises driven by technological innovation, occupying the five major industrial ecosystems of intelligent IoT, biomedicine, high-end equipment, new materials, green energy, and related future industry sectors, with explosive growth and industry-disrupting capabilities. This is an assessment of enterprises inIndustrial Positioning, Technological Disruption, and Market LeadershipComprehensive considerations.

The successful recognition as a "New Power" enterprise this time is an authoritative acknowledgment of Valgen Medtech's leading potential. In the emerging field of high-end medical devices, Valgen Medtech has demonstrated strong potential to grow into a "chain leader" enterprise that can reshape the industry landscape and lead industrial transformation, thanks to its breakthrough technology and well-established business model.

This latest authoritative recognition is not an isolated event, but rather the inevitable result of Valgen Medtech's long-term strategic advancement. From its core productsDragonFly™ Transcatheter Mitral Valve Clip System Successfully Approved in China and First to Obtain Rigorous EU CertificationMDRCertification: Valgen Medtech solidly builds its global competitiveness with every step.

This series of achievements collectively forms the solid foundation for Valgen Medtech's recognition as an "Emerging Force" enterprise, outlining a clear advancement path for an innovative company from technological breakthrough, market expansion to gaining continuous authoritative endorsement.

Dr. Tingchao Zhang, CEO of Valgen Medtech, stated: "This marks the beginning of a new journey. We will take this as motivation, adhere to innovation, and strive for greater heights in the industry. We are committed to providing a stronger answer from China on the global stage of medical technology."